Ozempic may lower the risk of serious complications from chronic kidney disease. Medical providers break down the latest research and potential links.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Question: I am a woman with a BMI of 31 and have recently been put on statins for high cholesterol. I have also been told ...

She is among many patients now asking why, with no apparent change in their blood test results, chronic kidney disease (CKD) is suddenly appearing as a problem on their medical charts. The answer is ...

CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...